Functional Block of Interleukin-6 Reduces a Bone Pain Marker but Not Bone Loss in Hindlimb-Unloaded Mice.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 May 2020
Historique:
received: 03 04 2020
revised: 08 05 2020
accepted: 13 05 2020
entrez: 21 5 2020
pubmed: 21 5 2020
medline: 11 2 2021
Statut: epublish

Résumé

Interleukin-6 (IL-6) is widely accepted to stimulate osteoclasts. Our aim in this study was to examine whether the inhibitory effect of IL-6 on bone loss and skeletal pain associated with osteoporosis in hindlimb-unloaded (HU) mice in comparison with bisphosphonate. Eight-week-old male ddY mice were tail suspended for 2 weeks. Starting immediately after reload, vehicle (HU group), alendronate (HU-ALN group), or anti-IL-6 receptor antibody (HU-IL-6i group) was injected subcutaneously. After a 2-week treatment, pain-related behavior was examined using von Frey filaments. The bilateral distal femoral and proximal tibial metaphyses were analyzed three-dimensionally with micro-computed tomography. Calcitonin gene-related peptide (CGRP) expressions in dorsal root ganglion (DRG) neurons innervating the hindlimbs were examined using immunohistochemistry. HU mice with tail suspension developed bone loss. The HU mice showed mechanical hyperalgesia in the hindlimbs and increased CGRP immunoreactive neurons in the L3-5 DRG. Treatment with IL-6i and ALN prevented HU-induced mechanical hyperalgesia and upregulation of CGRP expressions in DRG neurons. Furthermore, ALN but not IL-6i prevented HU-induced bone loss. In summary, treatment with IL-6i prevented mechanical hyperalgesia in hindlimbs and suppressed CGRP expressions in DRG neurons of osteoporotic models. The novelty of this research suggests that IL-6 is one of the causes of immobility-induced osteoporotic pain regardless improvement of bone loss.

Identifiants

pubmed: 32429268
pii: ijms21103521
doi: 10.3390/ijms21103521
pmc: PMC7278999
pii:
doi:

Substances chimiques

Biomarkers 0
Interleukin-6 0
Alendronate X1J18R4W8P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Calcif Tissue Int. 2002 Mar;70(3):176-85
pubmed: 11907715
Joint Bone Spine. 2011 Dec;78(6):572-6
pubmed: 21664854
Acta Physiol Scand. 2002 Dec;176(4):293-300
pubmed: 12444935
Rheumatology (Oxford). 2014 May;53(5):900-3
pubmed: 24441151
J Bone Miner Res. 2004 Jun;19(6):1006-12
pubmed: 15125798
Osteoporos Int. 2012 Sep;23(9):2347-57
pubmed: 22159671
Nature. 1994 Mar 24;368(6469):339-42
pubmed: 8127368
Eur J Pain. 2014 Feb;18(2):174-81
pubmed: 23821557
Int J Biochem Cell Biol. 2016 Oct;79:14-23
pubmed: 27497989
J Pain. 2010 Jul;11(7):652-62
pubmed: 20335076
Calcif Tissue Int. 2019 Jun;104(6):658-666
pubmed: 30666355
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
J Neuroimmunol. 1998 Apr 15;84(2):207-12
pubmed: 9628464
Environ Med. 2001 Dec;45(1):12-4
pubmed: 12353531
Annu Rev Pharmacol Toxicol. 1980;20:441-62
pubmed: 7387124
J Neurochem. 2006 Jul;98(1):180-92
pubmed: 16805807
J Appl Physiol (1985). 2016 May 15;120(10):1196-206
pubmed: 26869711
Bone. 2018 Jul;112:120-127
pubmed: 29679733
J Bone Miner Metab. 2018 May;36(3):274-285
pubmed: 28516219
Arthritis Rheumatol. 2016 Apr;68(4):857-67
pubmed: 26605536
Bone. 1986;7(2):109-17
pubmed: 3521685
Nutrition. 2002 Oct;18(10):849-52
pubmed: 12361777
J Biomech. 1992 May;25(5):489-99
pubmed: 1592854
Cell Immunol. 2001 May 1;209(2):140-8
pubmed: 11446746
Cytokine. 2014 Nov;70(1):11-20
pubmed: 24986424
J Clin Invest. 2004 Feb;113(3):379-89
pubmed: 14755335
Rheumatol Int. 2011 Nov;31(11):1445-9
pubmed: 20473503
J Orthop Res. 2015 Oct;33(10):1508-14
pubmed: 26010074
Eur J Pain. 2003;7(1):9-21
pubmed: 12527313
J Biol Chem. 2015 Jul 31;290(31):18934-42
pubmed: 26085098
Mol Med Rep. 2017 Dec;16(6):9367-9374
pubmed: 29039515
J Orthop Sci. 2018 Nov;23(6):1063-1069
pubmed: 30431005
Ann N Y Acad Sci. 2007 Nov;1116:281-90
pubmed: 17646259
Immunol Lett. 2002 Dec 3;84(3):231-40
pubmed: 12413742

Auteurs

Nobuto Nagao (N)

Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.

Sho Kato (S)

Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.

Yohei Naito (Y)

Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.

Akihiro Sudo (A)

Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH